Arax Advisory Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14K | Buy |
|
|||||
|
2025
Q1 | $1.38K | Sell |
|
|||||
|
2024
Q4 | $4.41K | Hold |
|
|||||
|
2024
Q3 | $3.8K | Sell |
|
|||||
|
2024
Q2 | $3.72K | Buy |
|
|||||
|
2024
Q1 | $1.19K | Sell |
|
|||||
|
2023
Q4 | $2.08K | Buy |
|
|||||
|
2023
Q3 | $1.85K | Hold |
|
|||||
|
2023
Q2 | $2.02K | Hold |
|
|||||
|
2023
Q1 | $2.43K | Hold |
|
|||||
|
2022
Q4 | $2.39K | Buy |
|
|||||
|
2022
Q3 | $1K | Hold |
|
|||||
|
2022
Q2 | $1K | Hold |
|
|||||
|
2022
Q1 | $1K | Hold |
|
|||||
|
2021
Q4 | $1K | Buy |
|